Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 32, Pages 19387-19401
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-05-22
DOI
10.1074/jbc.m115.656587
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Yes-associated protein 1 in gliomas: pathologic and therapeutic aspects
- (2015) Yong-Chang Liu et al. TUMOR BIOLOGY
- The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP
- (2015) Katherine Striedinger et al. NEOPLASIA
- The Hippo signaling pathway in stem cell biology and cancer
- (2014) J.-S. Mo et al. EMBO REPORTS
- Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
- (2014) Ning Liang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Making new contacts: the mTOR network in metabolism and signalling crosstalk
- (2014) Mitsugu Shimobayashi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Overcoming resistance to rapalogs in gliomas by combinatory therapies
- (2013) Michal Grzmil et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- mTOR in aging, metabolism, and cancer
- (2013) Marion Cornu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Nutrient regulation of the mTOR Complex 1 signaling pathway
- (2013) Sang Gyun Kim et al. MOLECULES AND CELLS
- Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
- (2012) Fa-Xing Yu et al. CELL
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP
- (2012) Eric Miller et al. CHEMISTRY & BIOLOGY
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Emerging insights into the molecular and cellular basis of glioblastoma
- (2012) G. P. Dunn et al. GENES & DEVELOPMENT
- Hippo–YAP and mTOR pathways collaborate to regulate organ size
- (2012) Alfred Csibi et al. NATURE CELL BIOLOGY
- YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
- (2012) Karen Tumaneng et al. NATURE CELL BIOLOGY
- Conditional Astroglial Rictor Overexpression Induces Malignant Glioma in Mice
- (2012) Tariq Bashir et al. PLoS One
- The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway
- (2012) Wanjin Hong et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Glioblastoma: From Molecular Pathology to Targeted Treatment
- (2011) Timothy F. Cloughesy et al. Annual Review of Pathology-Mechanisms of Disease
- Protor-2 interacts with tristetraprolin to regulate mRNA stability during stress
- (2011) Brent Holmes et al. CELLULAR SIGNALLING
- Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
- (2011) B. Zhao et al. GENES & DEVELOPMENT
- Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
- (2011) Siew Wee Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth
- (2011) Brent A. Orr et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
- (2011) Murugan Paramasivam et al. MOLECULAR BIOLOGY OF THE CELL
- Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
- (2011) C. Cloninger et al. MOLECULAR CANCER THERAPEUTICS
- Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
- (2011) K. Masui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
- (2011) A Fernandez-L et al. ONCOGENE
- The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
- (2011) P. P. Hsu et al. SCIENCE
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
- (2010) Nailing Zhang et al. DEVELOPMENTAL CELL
- Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
- (2010) Wenqi Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Deciphering Protein Kinase Specificity Through Large-Scale Analysis of Yeast Phosphorylation Site Motifs
- (2010) J. Mok et al. Science Signaling
- TOR complex 2: a signaling pathway of its own
- (2009) Nadine Cybulski et al. TRENDS IN BIOCHEMICAL SCIENCES
- Merlin Is a Potent Inhibitor of Glioma Growth
- (2008) Y.-K. I. Lau et al. CANCER RESEARCH
- Heterogeneous Nuclear Ribonucleoprotein A1 Regulates Cyclin D1 and c-mycInternal Ribosome Entry Site Function through Akt Signaling
- (2008) Oak D. Jo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now